Committed to sharing our science

Committed to sharing our science

scientist testing potential medicines

315 results available

Logistic and Economic Burden of Non-Obstructive Hypertrophic Cardiomyopathy – Results From Medical and Pharmacy Claims Data

Poster, AHA 2023
Butzner M, et al.
Philadelphia, PA
November 13, 2023
Healthcare Resource Utilization and Economic Burden Due to Atrial Fibrillation in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of 2016-2021 Claims Data

Poster, AHA 2023
Butzner M, et al.
Philadelphia, PA
November 13, 2023
Acute Treatment With Aficamten Rescues Contractile Function in a Myopod® Engineered Heart Tissue Model of Hypertrophic Cardiomyopathy

Poster, AHA 2023
Rupert C, et al.
Philadelphia, PA
November 11, 2023
Differences in Healthcare Resource Use and Cost by Treatment Choice Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of 2016-2021 Claims Data

Poster, AMCP Nexus 2023
Butzner M, et al.
Orlando, FL
October 17, 2023
A Phase 3 Randomized Controlled Trial Comparing Aficamten Vs Metoprolol In Patients With Symptomatic Hypertrophic Cardiomyopathy And Left Ventricular Outflow Tract Obstruction

Poster, Heart Failure Society of America 2023
Garcia-Pavia P, et al.
Cleveland, OH
October 7, 2023